Huntsman Cancer Institute at the University of Utah (the U) has joined other institutions in an innovative clinical trials program designed to match patients with acute myeloid leukemia (AML) and ...

Clinical trials are frightening endeavors for biotech investors. Expensive and fraught with risk, a trial’s failure can seriously lighten an investor’s pockets with little hope of recourse. After ...

Jeeva Clinical Trials, a leader in decentralized clinical trials technology announces the launch of its CRO Partnership Program to streamline & automate trials. Rare disease trials are already complex ...

ATLANTA, Nov. 17, 2025 /PRNewswire/ -- For individuals diagnosed with cancer, participation in a clinical trial offers the opportunity to explore new treatment options; however, for many, finding and ...

CEO Brian Lian highlighted the company's progress in advancing its VK2735 obesity program, with Phase 3 trials for the subcutaneous formulation set to begin later in Q2 2025. Additionally, enrollment ...